Novo Nordisk has been on the lookout for potential takeover targets but sees little strategic reason to jump into the deal-making wave sweeping the global pharmaceuticals sector.
from WSJ.com: US Business http://ift.tt/1qVs9V8
via IFTTT
from WSJ.com: US Business http://ift.tt/1qVs9V8
via IFTTT
No comments:
Post a Comment